Pathology Error Claims 2025: Misread Biopsies and Cancer Misdiagnosis

## The High Stakes of Pathology

Pathologists examine tissue and cells to diagnose disease, most importantly cancer. Their reports often determine whether a patient gets aggressive treatment, no treatment, or surgery. A pathology error can mean a missed cancer that grows untreated, or a false cancer diagnosis that leads to unnecessary chemotherapy or surgery. Both directions can be devastating.

This guide explains pathology errors and how claims work.

The Two Types of Pathology Errors

1. **False negatives**: the pathologist fails to identify cancer or another serious disease that was present in the specimen. The patient is reassured, the disease advances, and the diagnosis comes too late.
2. **False positives**: the pathologist diagnoses cancer that is not actually present, leading to unnecessary and harmful treatment such as mastectomy, prostatectomy, or chemotherapy.

Both can be malpractice if a competent pathologist would have read the slide correctly.

Where the Error Occurs

Pathology errors can arise at several points:

• **Specimen handling**: mislabeling, contamination, or mix-up of samples between patients.
• **Slide preparation**: poor sectioning or staining that obscures the diagnosis.
• **Interpretation**: misreading the cells under the microscope.
• **Reporting**: an ambiguous or incorrectly transcribed report.
• **Failure to order special studies** that the case required.

A specimen mix-up that gives one patient another's cancer diagnosis is a particularly tragic and litigated error.

The Standard of Care

Pathology is interpretive, and difficult cases can produce honest disagreement among experts. A claim requires showing the error fell below what a competent pathologist would have concluded. Often a second pathologist reviews the same slides to determine whether the diagnosis was reasonable or clearly wrong. Cases involving clear-cut features that were missed are the strongest.

Proving the Claim

Key evidence includes:

• **The original slides**, which can be re-reviewed years later, a major advantage in these cases.
• **The pathology report compared to the corrected diagnosis.**
• **Specimen tracking records** for mix-up cases.
• **Treatment records** showing what was done in reliance on the report.
• **Expert pathology testimony** on the misread.
• **Oncology testimony** on how the error changed the outcome.

Realistic Value Ranges

An error caught with limited harm may settle for $75,000 to $250,000. A false negative allowing a cancer to advance, or a false positive causing unnecessary organ removal, often reaches $500,000 to $2 million. Death cases are valued under wrongful death law.

Step-by-Step Action Plan

Step one: Request the actual slides and the pathology report, not just a summary.

Step two: Obtain a second opinion review of the slides from another pathologist.

Step three: Document the treatment you received or missed because of the report.

Step four: Track the timeline and how the error affected your prognosis.

Step five: Consult a malpractice attorney who works with pathology experts.

Frequently Asked Questions

Can old slides really be re-examined? Yes. Glass slides are typically retained for years and can be independently reviewed, which makes proving the original read possible.

What if two experts disagree? Reasonable disagreement is a defense. You win by showing the original read was clearly wrong, not merely debatable.

Is unnecessary chemotherapy a claim? Yes. A false positive that led to harmful, unneeded treatment is a recognized and serious pathology claim.

Who is liable for a specimen mix-up? Often the lab and the staff who handled the specimens, depending on where the swap occurred.